From insight to impact: Leveraging the AI-enabled Next platform with BMS to advance equitable access in precision oncology

May 27, 2026
Life Sciences
Webinar
Headshot of Andrew WhiteheadAndrew WhiteheadVP, Head of Population Health
Headshot of Noah ZimmermanNoah Zimmerman, PhD VP & GM, Next Oncology, Tempus
Headshot of Gary GradDr. Gary Grad Senior Medical Oncologist, Tempus

Session highlights

  • How AI-enabled platforms unify structured and unstructured data to reveal the "why" behind care decisions.

  • Real-world results, including an 8% lift in guideline-directed testing.

  • A discussion of how Tempus Next Pathways insights can support improved outcomes for patients, providers, and life sciences partners.

Related content

Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Abstract gradient fading from white and gray to bright blue with soft, rounded edges.

ESMO Congress 2026

Providers
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract background with a glowing blue-white curved line against a dark, textured surface.

Multimodal foundation models in action: Applications across drug development

2026-10-15
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
Abstract background with subtle wavy lines creating a dynamic pattern in shades of grey.

Closing gaps in early-stage NSCLC with AI-enabled clinical intelligence

2026-10-14
Life Sciences